Cited by 2,641Clostridium difficile and Clostridium perfringens researchInfection Control in HealthcareAntimicrobial Resistance in Staphylococcus

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

Burden of Clostridium difficile Infection in the United States

Open access

Lessa, Fernanda C., Mu, Yi, Bamberg, Wendy M., Beldavs, Zintars G., Dumyati, Ghinwa K., Dunn, John R., Farley, Monica M., Holzbauer, Stacy M., Meek, James I., Phipps, Erin C., Wilson, Lucy E., Winston, Lisa G., Cohen, Jessica A., Limbago, Brandi M., Fridkin, Scott K., Gerding, Dale N., McDonald, L. Clifford·2015·New England Journal of Medicine

DOI 10.1056/nejmoa1408913PMC PMC10966662

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: The magnitude and scope of Clostridium difficile infection in the United States continue to evolve. METHODS: In 2011, we performed active population- and laboratory-based surveillance across 10 geographic areas in the United States to identify cases of C. difficile infection (stool specimens positive for C. difficile on either toxin or molecular assay in residents ≥ 1 year of age). Cases were classified as community-associated or health care-associated. In a sample of cases of C. difficile infection, specimens were cultured and isolates underwent molecular typing. We used regression models to calculate estimates of national incidence and total number of infections, first recurrences, and deaths within 30 days after the diagnosis of C. difficile infection. RESULTS: A total of 15,461 cases of C. difficile infection were identified in the 10 geographic areas; 65.8% were health care-associated, but only 24.2% had onset during hospitalization. After adjustment for predictors of disease incidence, the estimated number of incident C. difficile infections in the United States was 453,000 (95% confidence interval [CI], 397,100 to 508,500). The incidence was estimated to be higher among females (rate ratio, 1.26; 95% CI, 1.25 to 1.27), whites (rate ratio, 1.72; 95% CI, 1.56 to 2.0), and persons 65 years of age or older (rate ratio, 8.65; 95% CI, 8.16 to 9.31). The estimated number of first recurrences of C. difficile infection was 83,000 (95% CI, 57,000 to 108,900), and the estimated number of deaths was 29,300 (95% CI, 16,500 to 42,100). The North American pulsed-field gel electrophoresis type 1 (NAP1) strain was more prevalent among health care-associated infections than among community-associated infections (30.7% vs. 18.8%, P<0.001). CONCLUSIONS: C. difficile was responsible for almost half a million infections and was associated with approximately 29,000 deaths in 2011. (Funded by the Centers for Disease Control and Prevention.).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejmoa1408913

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Multistate point-prevalence survey of health care-associated infections
Magill, S. S., Edwards, J. R., Bamberg, W., Beldavs, Z. G., Dumyati, G., Kainer, M. A., Lynfield, R., Maloney, M., McAllister-Hollod, L., Nadle, J., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1306801 · Cited by 3,931
Self-citation
Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)
Cohen, S. H., Gerding, D. N., Johnson, S., Kelly, C. P., Loo, V. G., McDonald, L. C., Pépin, J., & Wilcox, M. H. (2010) · Infection Control and Hospital Epidemiology · doi:10.1086/651706 · Cited by 2,965
Self-citation
Sampling: Design and Analysis
Ziegel, E. R., & Lohr, S. L. (2000) · Technometrics · doi:10.2307/1271491 · Cited by 2,452
An Epidemic, Toxin Gene–Variant Strain of Clostridium difficile
McDonald, L. C., Killgore, G., Thompson, A. D., Owens, R. C., Kazakova, S. V., Sambol, S. P., Johnson, S., & Gerding, D. N. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051590 · Cited by 2,020
Self-citation
A Predominantly Clonal Multi-Institutional Outbreak ofClostridium difficile–Associated Diarrhea with High Morbidity and Mortality
Loo, V. G., Poirier, L., Miller, M. A., Oughton, M., Libman, M., Michaud, S., Bourgault, A., Nguyen, T., Frenette, C. H., Kelly, M., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051639 · Cited by 1,962
Clostridium difficile infection in Europe: a hospital-based survey
Bauer, M. P., Notermans, D. W., BENTHEM, B. H. B. V., Brazier, J. S., Wilcox, M. H., Rupnik, M., Monnet, D. L., van Dissel, J. T., & Kuijper, E. J. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61266-4 · Cited by 1,049
The Changing Epidemiology of Clostridium difficile Infections
Freeman, J., Bauer, M. P., Baines, S. D., Corver, J., Fawley, W. N., Goorhuis, A., Kuijper, E. J., & Wilcox, M. H. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00082-09 · Cited by 838
Treatment with Monoclonal Antibodies against Clostridium difficile Toxins
Lowy, I., Molrine, D. C., Leav, B. A., Blair, B. M., Baxter, R. P., Gerding, D. N., Nichol, G. M., Thomas, W. D., Leney, M. D., Sloan, S. E., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907635 · Cited by 743
Self-citation
Burden of Clostridium difficile on the Healthcare System
Dubberke, E. R., & Olsen, M. A. A. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis335 · Cited by 566
Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C difficile infection
Planche, T., Davies, K., Coen, P. G., Finney, J. M., Monahan, I. M., Morris, K. A., O’Connor, L., Oakley, S. J., Pope, C. F., Wren, M. W. D., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70200-7 · Cited by 436

Show all 44 references

Research works printed but not linked: 4

2005, MMWR Morb Mortal Wkly Rep, 54, 1201
Heitjan DF, 1991, J R Stat Soc Ser C Appl Stat, 40, 13
2014, Fed Regist, 79, 10524
2011, Fed Regist, 76, 51476

Sorted by citations

Items 601–700 of 1,002

Toxin-positive Clostridium difficile latently infect mouse colonies and protect against highly pathogenic C. difficile
Etienne‐Mesmin, L., Chassaing, B., Adekunle, O., Mattei, L. M., Bushman, F. D., & Gewirtz, A. T. (2017) · Gut · doi:10.1136/gutjnl-2016-313510 · Cited by 35
Identification of novel risk factors for community-acquired Clostridium difficile infection using spatial statistics and geographic information system analyses
Anderson, D. J., Rojas, L. F., Watson, S., Knelson, L. P., Pruitt, S., Lewis, S. S., Moehring, R. W., Bennett, E. E. S., Weber, D. J., Chen, L. F., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176285 · Cited by 35
Control of Clostridium difficile Infection by Defined Microbial Communities
Collins, J., & Auchtung, J. M. (2017) · Microbiology Spectrum · doi:10.1128/microbiolspec.bad-0009-2016 · Cited by 39
Adaptive immune response to Clostridium difficile infection: A perspective for prevention and therapy
Rees, W. D., & Steiner, T. S. (2017) · European Journal of Immunology · doi:10.1002/eji.201747295 · Cited by 35
Wisconsin microbiome study, a cross-sectional investigation of dietary fibre, microbiome composition and antibiotic-resistant organisms: rationale and methods
Eggers, S. I., Malecki, K. M. C., Peppard, P. E., Mares, J. A., Shirley, D. K., Shukla, S. K., Poulsen, K. P., Gangnon, R. E., Duster, M. N., Kates, A., et al. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-019450 · Cited by 35
Clostridium difficile Lipoprotein GerS Is Required for Cortex Modification and Thus Spore Germination
Diaz, O. R., Sayer, C. V., Popham, D. L., & Shen, A. (2018) · mSphere · doi:10.1128/msphere.00205-18 · Cited by 35
Cwp22, a novel peptidoglycan cross‐linking enzyme, plays pleiotropic roles in Clostridioides difficile
Zhu, D., Bullock, J., He, Y. O., & Sun, X. (2019) · Environmental Microbiology · doi:10.1111/1462-2920.14706 · Cited by 35
Protection from Lethal Clostridioides difficile Infection via Intraspecies Competition for Cogerminant
Leslie, J. L., Jenior, M. L., Vendrov, K. C., Standke, A. K., Barron, M. R., O’Brien, T. J., Unverdorben, L. V., Thaprawat, P., Bergin, I. L., Schloss, P. D., et al. (2021) · mBio · doi:10.1128/mbio.00522-21 · Cited by 35
Fecal Mycobiota Combined With Host Immune Factors Distinguish Clostridioides difficile Infection From Asymptomatic Carriage
Cao, Y., Wang, L., Ke, S., Villafuerte-Gálvez, J., Pollock, N. R., Barrett, C. G., Sprague, R., Daugherty, K., Xu, H. J., Lin, Q., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.02.069 · Cited by 36
Colon-Targeted Delivery of IgY Against Clostridium difficile Toxin A and B by Encapsulation in Chitosan-Ca Pectinate Microbeads
Xing, P., Shi, Y., Dong, C., Liu, H., Cheng, Y., Sun, J., Li, D., Li, M., Sun, K., & Feng, D. (2016) · AAPS PharmSciTech · doi:10.1208/s12249-016-0656-2 · Cited by 35
Bezlotoxumab — A New Agent forClostridium difficileInfection
Bartlett, J. G. (2017) · New England Journal of Medicine · doi:10.1056/nejme1614726 · Cited by 35
Clinical Outcomes and Management of NAAT-Positive/Toxin-Negative Clostridioides difficile Infection: A Systematic Review and Meta-Analysis
Prosty, C. J., Hanula, R., Katergi, K., Longtin, Y., McDonald, E. G., & Lee, T. C. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad523 · Cited by 35
Engineering Lipid Nanoparticles for mRNA Immunotherapy
Zwolsman, R. C., Darwish, Y. B., Kluza, E., & van der Meel, R. (2025) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.70007 · Cited by 38
High Variability in Nosocomial Clostridium difficile Infection Rates Across Hospitals After Colorectal Resection
Aquina, C. T., Probst, C. P., Becerra, A. Z., Hensley, B. J., Iannuzzi, J. C., Noyes, K., Monson, J. R. T., & Fleming, F. J. (2016) · Diseases of the Colon & Rectum · doi:10.1097/dcr.0000000000000539 · Cited by 34
Isolation of C. difficile Carriers Alone and as Part of a Bundle Approach for the Prevention of Clostridium difficile Infection (CDI): A Mathematical Model Based on Clinical Study Data
Grigoras, C. A., Zervou, F. N., Zacharioudakis, I. M., Siettos, C. I., & Mylonakis, E. E. (2016) · PLoS ONE · doi:10.1371/journal.pone.0156577 · Cited by 34
Prevalence and molecular characterization of Clostridium difficile isolates from a pig slaughterhouse, pork, and humans in Taiwan
Wu, Y., Chen, C., Kuo, C., Lee, J., Chen, P.-C., Chang, Y., & Chen, T.-H. (2016) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2016.11.010 · Cited by 34
An online course improves nurses' awareness of their role as antimicrobial stewards in nursing homes
Wilson, B. M., Simonson-Shick, S., Carter, R. R., Heath, B. M., Higgins, P. A., Sychla, B., Olds, D. M., & Jump, R. (2017) · American Journal of Infection Control · doi:10.1016/j.ajic.2017.01.002 · Cited by 34
Evolving Insights Into the Epidemiology and Control of Clostridium difficile in Hospitals
Caroff, D. A., Yokoe, D. S., & Klompas, M. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix456 · Cited by 34
Can improving patient hand hygiene impact Clostridium difficile infection events at an academic medical center?
Pokrywka, M., Buraczewski, M., Frank, D., Dixon, H. J., Ferrelli, J. G., Shutt, K. A., & Yassin, M. (2017) · American Journal of Infection Control · doi:10.1016/j.ajic.2017.06.019 · Cited by 34
Predictors of Mortality Among a National Cohort of Veterans With Recurrent Clostridium difficile Infection
Appaneal, H. J., Caffrey, A. R., Beganovic, M., Avramovic, S., & LaPlante, K. L. (2018) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy175 · Cited by 34
Prevalence and Strain Characterization of Clostridioides (Clostridium) difficile in Representative Regions of Germany, Ghana, Tanzania and Indonesia – A Comparative Multi-Center Cross-Sectional Study
Seugendo, M., Janssen, I., Lang, V., Hasibuan, I., Bohne, W., Cooper, P., Daniel, R., Gunka, K., Kusumawati, R. L., Mshana, S. E., et al. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01843 · Cited by 34
Environmental shedding of toxigenic Clostridioides difficile by asymptomatic carriers: A prospective observational study
Gilboa, M., Houri-Levi, E., Cohen, C., Tal, I., Rubin, C., Feld-Simon, O., Brom, A., Eden-Friedman, Y., Segal, S., Rahav, G., et al. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.12.011 · Cited by 34
The Role of Diagnostic Stewardship in Clostridioides difficile Testing: Challenges and Opportunities
Boly, F., Reske, K. A., & Kwon, J. H. (2020) · Current Infectious Disease Reports · doi:10.1007/s11908-020-0715-4 · Cited by 34
Incidence, Etiology, and Severity of Acute Gastroenteritis Among Prospectively Enrolled Patients in 4 Veterans Affairs Hospitals and Outpatient Centers, 2016–2018
Cardemil, C. V., Balachandran, N., Kambhampati, A. K., Grytdal, S., Dahl, R. M., Rodriguez‐Barradas, M. C., Vargas, B., Beenhouwer, D. O., Evangelista, K. V., Marconi, V. C., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa806 · Cited by 34
Antimicrobial Stewardship Practice in the Ambulatory Setting From a National Cohort
Eudy, J., Pallotta, A. M., Neuner, E. A., Brummel, G. L., Postelnick, M. J., Schulz, L. T., Spivak, E. S., & Wrenn, R. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa513 · Cited by 34
Clostridium difficile Infection in Pediatric Inflammatory Bowel Disease
Hourigan, S. K., Sears, C. L., & Oliva‐Hemker, M. M. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000666 · Cited by 34
Acid-Suppressive Therapy and Risk of Infections: Pros and Cons
Fisher, L., & Fisher, A. (2017) · Clinical Drug Investigation · doi:10.1007/s40261-017-0519-y · Cited by 37
Modulation of Intestinal Paracellular Transport by Bacterial Pathogens
Roxas, J. L., & Viswanathan, V. K. (2018) · Comprehensive physiology · doi:10.1002/cphy.c170034 · Cited by 34
Clostridium difficile Infection
Bartlett, J. G. (2017) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2017.05.012 · Cited by 33
The incidence and outcomes from Clostridium difficile infection in hospitalized adults with inflammatory bowel disease
Saffouri, G. B., Gupta, A., Loftus, E. V., Baddour, L. M., Pardi, D. S., & Khanna, S. (2017) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2017.1362466 · Cited by 33
Diverse bacterial species contribute to antibiotic-associated diarrhoea and gastrointestinal damage
Larcombe, S., Hutton, M. L., Riley, T. V., Abud, H. E., & Lyras, D. (2018) · Journal of Infection · doi:10.1016/j.jinf.2018.06.006 · Cited by 33
Increased age and proton pump inhibitors are associated with severe Clostridium difficile infections in children
Chang, T., Hsu, W.-Y., Yang, T.-I., Lu, C., Hsueh, P., Chen, J., Lee, P., Huang, L., & Chang, L. (2018) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2018.09.002 · Cited by 33
The first isolation of Clostridium difficile RT078/ST11 from pigs in China
Zhang, L., Yang, L., Gu, X., Chen, P.-X., Fu, J., & Jiang, H. (2019) · PLoS ONE · doi:10.1371/journal.pone.0212965 · Cited by 33
Saccharomyces boulardii CNCM I-745 Modulates the Fecal Bile Acids Metabolism During Antimicrobial Therapy in Healthy Volunteers
Kelly, C. P., Chong-Nguyen, C., Palmieri, L., Pallav, K., Dowd, S. E., Humbert, L., Seksik, P., Bado, A., Coffin, B., Rainteau, D. P., et al. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00336 · Cited by 36
Clostridioides difficileWhole-genome Sequencing Differentiates Relapse With the Same Strain From Reinfection With a New Strain
Cho, J. M., Cunningham, S. A., Pu, M., Lennon, R. J., Higano, J. D., Jeraldo, P., Sampathkumar, P., Shannon, S. K., Kashyap, P., & Patel, R. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa159 · Cited by 33
The Route to Palatable Fecal Microbiota Transplantation
Fadda, H. M. (2020) · AAPS PharmSciTech · doi:10.1208/s12249-020-1637-z · Cited by 36
Identification of Simplified Microbial Communities That Inhibit Clostridioides difficile Infection through Dilution/Extinction
Auchtung, J. M., Preisner, E. C., Collins, J., Lerma, A. I., & Britton, R. A. (2020) · mSphere · doi:10.1128/msphere.00387-20 · Cited by 32
Antimicrobial resistance surveillance of Clostridioides difficile in Australia, 2015–18
Putsathit, P., Hong, S., George, N., Hemphill, C., Huntington, P. G., Korman, T. M., Kotsanas, D., Lahra, M. M., McDougall, R. J., McGlinchey, A., et al. (2021) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkab099 · Cited by 33
Fecal Microbiota Transplantation for Severe or Fulminant Clostridioides difficile Infection: Systematic Review and Meta-analysis
Song, Y., Yang, D. Y., van Zanten, S. V., Wong, K., McArthur, E., Song, C. Z., Ianiro, G., Cammarota, G., Kelly, C. R., Fischer, M., et al. (2021) · Journal of the Canadian Association of Gastroenterology · doi:10.1093/jcag/gwab023 · Cited by 33
Novel Drivers of Virulence in Clostridioides difficile Identified via Context-Specific Metabolic Network Analysis
Jenior, M. L., Leslie, J. L., Powers, D. A., Garrett, E. M., Walker, K. A., Dickenson, M. E., Petri, W. A., Tamayo, R., & Papin, J. A. (2021) · mSystems · doi:10.1128/msystems.00919-21 · Cited by 30
Next-Generation Probiotic Therapy to Protect the Intestines From Injury
Ragan, M. V., Wala, S. J., Goodman, S. D., Bailey, M. T., & Besner, G. E. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.863949 · Cited by 33
Proton Pump Inhibitor-Induced Gut Dysbiosis Increases Mortality Rates for Patients with Clostridioides difficile Infection
Lin, C.-Y., Cheng, H., Kuo, C., Lee, Y., Sung, C., Keidan, M., Rao, K. K., Kao, J. Y., & Hsieh, S. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.00486-22 · Cited by 37
Analysis of gut microbiota – An ever changing landscape
Sadowsky, M. J., Staley, C. M., Heiner, C. R., Hall, R. J., Kelly, C. R., Brandt, L. J., & Khoruts, A. (2017) · Gut Microbes · doi:10.1080/19490976.2016.1277313 · Cited by 33
Evaluation of bloodstream infections, Clostridium difficile infections, and gut microbiota in pediatric oncology patients
Nycz, B. T., Dominguez, S. R., Friedman, D., Hilden, J. M., Ir, D., Robertson, C. E., & Frank, D. N. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191232 · Cited by 35
Selection and characterization of ultrahigh potency designed ankyrin repeat protein inhibitors of C. difficile toxin B
Simeon, R. L., Jiang, M., Chamoun‐Emanuelli, A. M., Yu, H., Zhang, Y., Meng, R., Peng, Z., Jakana, J., Zhang, J., Feng, H., et al. (2019) · PLoS Biology · doi:10.1371/journal.pbio.3000311 · Cited by 33
Butyrate Protects against Clostridium difficile Infection by Regulating Bile Acid Metabolism
Wang, S., Xiang, L., Li, F., Deng, W., Lv, P., & Chen, Y. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.04479-22 · Cited by 32
Novel antibiotics in development to treat Clostridium difficile infection
Bassères, E., Endres, B. T., Dotson, K. M., Alam, M. J., & Garey, K. W. (2016) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000332 · Cited by 32
Clostridium difficile Infection and Patient-Specific Antimicrobial Resistance Testing Reveals a High Metronidazole Resistance Rate
Barkin, J. A., Sussman, D. A., Fifadara, N., & Barkin, J. S. (2017) · Digestive Diseases and Sciences · doi:10.1007/s10620-017-4462-9 · Cited by 32
Impact of the NAP-1 strain on disease severity, mortality, and recurrence of healthcare-associated Clostridium difficile infection
Bauer, K. A. A., Johnston, J., Wenzler, E., Goff, D. A., Cook, C. H., Balada-Llasat, J.-M., Pancholi, P., & Mangino, J. E. (2017) · Anaerobe · doi:10.1016/j.anaerobe.2017.06.009 · Cited by 32
Probiotic containing Lactobacillus casei , Lactobacillus bulgaricus , and Streptococcus thermophiles (ACTIMEL) for the prevention of Clostridium difficile associated diarrhoea in the elderly with proximal femur fractures
Mallina, R. K., Craik, J., Briffa, N., Ahluwalia, V., Clarke, J., & Cobb, A. G. (2017) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2017.04.001 · Cited by 32
Is there a relationship between the presence of the binary toxin genes in Clostridium difficile strains and the severity of C. difficile infection (CDI)?
Berry, C., Davies, K. J. A., Owens, D., & Wilcox, M. H. (2017) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-017-3075-8 · Cited by 32
Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolated from the Chinese People’s Liberation Army General Hospital in China
Wang, R., Suo, L., Chen, H. X., Song, L. J., Shen, Y. Y., & Luo, Y. P. (2017) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2017.07.010 · Cited by 32
Applying fecal microbiota transplantation (FMT) to treat recurrent Clostridium difficile infections (rCDI) in children
Fareed, S., Sarode, N., Stewart, F. J., Malik, A., Laghaie, E., Khizer, S., Yan, F., Pratte, Z. A., Lewis, J. D., & Immergluck, L. C. (2018) · PeerJ · doi:10.7717/peerj.4663 · Cited by 32
N-Deacetylases required for muramic-δ-lactam production are involved in Clostridium difficile sporulation, germination, and heat resistance
Coullon, H., Rifflet, A., Wheeler, R., Janoir, C., Boneca, I. G., & Candela, T. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.004273 · Cited by 32
The Fatty Acid Synthesis Protein Enoyl-ACP Reductase II (FabK) is a Target for Narrow-Spectrum Antibacterials for Clostridium difficile Infection
Marreddy, R. K. R., Wu, X., Sapkota, M., Prior, A. M., Jones, J. A., Sun, D., Hevener, K. E., & Hurdle, J. G. (2018) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.8b00205 · Cited by 32
Survey, characterization and antimicrobial susceptibility of Clostridium difficile from marine bivalve shellfish of North Adriatic Sea
Agnoletti, F., Arcangeli, G., Barbanti, F., Barco, L., Brunetta, R., Cocchi, M., Conedera, G., D’Este, L., Drigo, I., Spigaglia, P., et al. (2019) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2019.03.003 · Cited by 32
Does Addition of Intravenous Metronidazole to Oral Vancomycin Improve Outcomes in Clostridioides difficile Infection?
Wang, Y., Schluger, A., Li, J., Gomez‐Simmonds, A., Salmasian, H., & Freedberg, D. E. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz1115 · Cited by 32
Evaluation of the Cost-effectiveness of Infection Control Strategies to Reduce Hospital-Onset Clostridioides difficile Infection
Barker, A., Scaria, E., Safdar, N., & Alagöz, O. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.12522 · Cited by 32
The Stickland Reaction Precursor trans -4-Hydroxy- l -Proline Differentially Impacts the Metabolism of Clostridioides difficile and Commensal Clostridia
Reed, A. D., Fletcher, J. R., Huang, Y. Y., Thanissery, R., Rivera, A. J., Parsons, R., Stewart, A. K., Kountz, D. J., Shen, A., Balskus, E. P., et al. (2022) · mSphere · doi:10.1128/msphere.00926-21 · Cited by 31
Glucosyltransferase-dependent and independent effects of Clostridioides difficile toxins during infection
Peritore‐Galve, F. C., Shupe, J. A., Cave, R. J., Childress, K. O., Washington, M. K., Kuehne, S. A., & Lacy, D. B. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010323 · Cited by 32
Engaging hospitalists in antimicrobial stewardship: Lessons from a multihospital collaborative
Mack, M., Rohde, J. M., Jacobsen, D., Barron, J. R., Ko, C., Goonewardene, M., Rosenberg, D. J., Srinivasan, A., & Flanders, S. A. (2016) · Journal of Hospital Medicine · doi:10.1002/jhm.2599 · Cited by 32
Faecal lactoferrin and calprotectin in patients with Clostridium difficile infection: a case–control study
Barbut, F., Gouot, C., Lapidus, N., Suzon, L., Syed-Zaidi, R., Lalande, V., & Eckert, C. (2017) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-017-3080-y · Cited by 32
Hygienemaßnahmen bei Clostridioides difficile-Infektion (CDI)
(2019) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-019-02959-1 · Cited by 32
Incidence and Outcome of Clostridium difficile Infection in Hospitalized Patients with Inflammatory Bowel Disease in the UK
Joshi, N. M., Marks, I. H., Crowson, R., Ball, D. E., & Rampton, D. S. (2016) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjw117 · Cited by 31
Vital Signs: Preventing Antibiotic‐Resistant Infections in Hospitals — United States, 2014
Weiner, L. M., Fridkin, S. K., Torres, Z. A., Avery, L., Coffin, N., Dudeck, M. A., Edwards, J. R., Jernigan, J. A., Konnor, R. Y., Soe, M. M., et al. (2016) · American Journal of Transplantation · doi:10.1111/ajt.13893 · Cited by 31
Self-citation
Cadazolid for the treatment of Clostridium difficile
Endres, B. T., Bassères, E., Alam, M. J., & Garey, K. W. (2017) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2017.1304538 · Cited by 31
Genomic survey of Clostridium difficile reservoirs in the East of England implicates environmental contamination of wastewater treatment plants by clinical lineages
Moradigaravand, D., Gouliouris, T., Ludden, C., Reuter, S., Jamrozy, D. M., Blane, B., Naydenova, P., Judge, K., Aliyu, S. H., Hadjirin, N. F., et al. (2018) · Microbial Genomics · doi:10.1099/mgen.0.000162 · Cited by 33
Association of Medical Microbiology and Infectious Disease Canada treatment practice guidelines for Clostridium difficile infection
Loo, V. G., Davis, I. R., Embil, J. M., Evans, G. A., Hota, S. S., Lee, C., Lee, T. C., Longtin, Y., Louie, T., Moayyedi, P., et al. (2018) · Journal of the Association of Medical Microbiology and Infectious Disease Canada · doi:10.3138/jammi.2018.02.13 · Cited by 30
Molecular epidemiology of Clostridium difficile infection in Iranian hospitals
Shoaei, P., Shojaei, H., Khorvash, F., Hosseini, S. M., Ataei, B., Tavakoli, H., Jalali, M., & Weese, J. S. (2019) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-018-0454-6 · Cited by 31
Model to evaluate the impact of hospital-based interventions targeting false-positive blood cultures on economic and clinical outcomes
Geisler, B. P., Jilg, N., Patton, R., & Pietzsch, J. B. (2019) · Journal of Hospital Infection · doi:10.1016/j.jhin.2019.03.012 · Cited by 31
Acid Suppression Medications During Hospitalization as a Risk Factor for Recurrence of Clostridioides difficile Infection: Systematic Review and Meta-analysis
Mehta, P., Nahass, R., & Brunetti, L. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa545 · Cited by 31
Recurrent Clostridioides difficile infection: Recognition, management, prevention
Tsigrelis, C. (2020) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.87gr.20001 · Cited by 30
Oral vancomycin prophylaxis for the prevention of Clostridium difficile infection: A systematic review and meta-analysis
Babar, S., Kurdi, B. E., Iskandarani, M. E., Haddad, I., Imam, Z., Alomari, M., Myers, J. W., & Moorman, J. P. (2020) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2020.277 · Cited by 31
A novel probiotic therapeutic in a murine model of Clostridioides difficile colitis
Shelby, R. D., Janzow, G. E., Mashburn‐Warren, L., Galley, J. D., Tengberg, N., Navarro, J. B., Conces, M. R., Bailey, M. T., Goodman, S. D., & Besner, G. E. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1814119 · Cited by 31
Phylogenomic analysis of Clostridioides difficile ribotype 106 strains reveals novel genetic islands and emergent phenotypes
Roxas, B. P., Roxas, J. L., Claus-Walker, R. A., Harishankar, A., Mansoor, A., Anwar, F., Jillella, S., Williams, A., Lindsey, J., Elliott, S. P., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-79123-2 · Cited by 31
Isobavachalcone From Cullen corylifolium Presents Significant Antibacterial Activity Against Clostridium difficile Through Disruption of the Cell Membrane
Liu, X., Yang, Y., Qin, Z., Li, S., Bai, L., Ge, W.-B., & Li, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.914188 · Cited by 31
Potentially hypervirulent Clostridium difficile PCR ribotype 078 lineage isolates in pigs and possible implications for humans in Taiwan
Wu, Y.-C., Lee, J.-J., Tsai, B., Liu, Y.-F., Chen, C., Tien, N., Tsai, P.-J., & Chen, T.-H. (2016) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2016.02.002 · Cited by 31
Host Cell Chaperones Hsp70/Hsp90 and Peptidyl-Prolyl Cis/Trans Isomerases Are Required for the Membrane Translocation of Bacterial ADP-Ribosylating Toxins
Ernst, K., Schnell, L., & Barth, H. (2016) · Current topics in microbiology and immunology · doi:10.1007/82_2016_14 · Cited by 31
Marine Mammal Microbiota Yields Novel Antibiotic with Potent Activity Against Clostridium difficile
Ochoa, J. L., Sanchez, L. M., Koo, B., Doherty, J. S., Rajendram, M., Huang, K. C., Gross, C. A., & Linington, R. G. (2017) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.7b00105 · Cited by 30
Clostridium difficile forms variable biofilms on abiotic surface
Pantaleon, V., Monot, M., Eckert, C., Hoÿs, S., Collignon, A., Janoir, C., & Candela, T. (2018) · Anaerobe · doi:10.1016/j.anaerobe.2018.05.006 · Cited by 36
Fecal Microbiota Transplantation: Past, Present and Future
Евдокимова, Н. В., & Chernenkaya, T. V. (2019) · Russian Sklifosovsky Journal Emergency Medical Care · doi:10.23934/2223-9022-2019-8-2-160-165 · Cited by 31
PCR ribotypes of Clostridioides difficile across Texas from 2011 to 2018 including emergence of ribotype 255
Gonzales-Luna, A. J., Carlson, T. J., Dotson, K. M., Poblete, K., da Costa, G. A. P. C., Miranda, J. M., Lancaster, C. K., Walk, S. T., Tupy, S., Begum, K., et al. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1721335 · Cited by 30
Antibiotics Associated With Clostridium difficile Infection
Rafey, A., Jahan, S., Farooq, U., Akhtar, F., Irshad, M., Nizamuddin, S., & Parveen, A. (2023) · Cureus · doi:10.7759/cureus.39029 · Cited by 30
Lactobacillus paracasei ZFM54 alters the metabolomic profiles of yogurt and the co-fermented yogurt improves the gut microecology of human adults
Chen, X., Zhu, Z., Zhang, X., Chen, L., Gu, Q., & Li, P. (2024) · Journal of Dairy Science · doi:10.3168/jds.2023-24332 · Cited by 31
Systems Modeling of Interactions between Mucosal Immunity and the Gut Microbiome during Clostridium difficile Infection
Leber, A. J., Viladomiu, M., Hontecillas, R., Abedi, V., Philipson, C. W., Hoops, S., Howard, B. A., & Bassaganya-Riera, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134849 · Cited by 31
Effect of an antimicrobial stewardship bundle for patients withClostridium difficileinfection
Brumley, P. E., Malani, A. N., Kabara, J. J., Pisani, J., & Collins, C. D. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv404 · Cited by 30
Use of probiotics in prevention and treatment of patients with Clostridium difficile infection
Ollech, J. E., Shen, N. T., Crawford, C. V., & Ringel, Y. (2016) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2016.01.002 · Cited by 30
Principles of DNA-Based Gut Microbiota Assessment and Therapeutic Efficacy of Fecal Microbiota Transplantation in Gastrointestinal Diseases
Cammarota, G., Pecere, S., Ianiro, G., Masucci, L., & Currò, D. (2016) · Digestive Diseases · doi:10.1159/000443362 · Cited by 30
Differences in the Molecular Epidemiology and Antibiotic Susceptibility of Clostridium difficile Isolates in Pediatric and Adult Patients
Kociolek, L. K., Gerding, D. N., Osmolski, J. R., Patel, S. J., Snydman, D. R., McDermott, L. A., & Hecht, D. W. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00714-16 · Cited by 30
Self-citation
Characteristics and Immunological Roles of Surface Layer Proteins inClostridium difficile
Mori, N., & Takahashi, T. (2018) · Annals of Laboratory Medicine · doi:10.3343/alm.2018.38.3.189 · Cited by 30
How Common—and How Serious— Is Clostridium difficile Colitis After Geriatric Hip Fracture? Findings from the NSQIP Dataset
Bovonratwet, P., Bohl, D. D., Russo, G. S., Ondeck, N. T., Nam, D., Valle, C. J. D., & Grauer, J. N. (2018) · Clinical Orthopaedics and Related Research · doi:10.1007/s11999.0000000000000099 · Cited by 30
Impact of CodY protein on metabolism, sporulation and virulence in Clostridioides difficile ribotype 027
Daou, N., Wang, Y., Levdikov, V. M., Nandakumar, M., Livny, J., Bouillaut, L., Blagova, E. V., Zhang, K., Belitsky, B. R., Rhee, K. Y., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0206896 · Cited by 30
Epidemiology of Clostridium difficile infection in hospitalized adults and the first isolation of C. difficile PCR ribotype 027 in central China
Zhou, Y., Mao, L., Yu, J., Lin, Q., Luo, Y., Zhu, X., & Sun, Z. (2019) · BMC Infectious Diseases · doi:10.1186/s12879-019-3841-6 · Cited by 30
The C. difficile clnRAB operon initiates adaptations to the host environment in response to LL-37
Woods, E. C., Edwards, A. N., Childress, K. O., Jones, J. B., & McBride, S. M. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1007153 · Cited by 30
The Use of Preoperative Antibiotics in Elective Soft-Tissue Procedures in the Hand
Shapiro, L. M., Zhuang, T., Li, K., & Kamal, R. N. (2019) · JBJS Reviews · doi:10.2106/jbjs.rvw.18.00168 · Cited by 30
Predictors of Clostridioides difficile Infection-Related Complications and Treatment Patterns among Nucleic Acid Amplification Test-Positive/Toxin Enzyme Immunoassay-Negative Patients
Miller, R., Morillas, J. A., Brizendine, K. D., & Fraser, T. G. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.01764-19 · Cited by 30
Faecal Microbiota Transplantation is Effective for the Initial Treatment of Clostridium difficile Infection: A Retrospective Clinical Review
Roshan, N., Clancy, A. K., & Borody, T. J. (2020) · Infectious Diseases and Therapy · doi:10.1007/s40121-020-00339-w · Cited by 30
Diagnosis and Treatment of Clostridium difficile Infection
Gerding, D. N., File, T. M., & McDonald, L. C. (2015) · Infectious Diseases in Clinical Practice · doi:10.1097/ipc.0000000000000350 · Cited by 30
Self-citation
Phase‐variable expression of pdcB , a phosphodiesterase, influences sporulation in Clostridioides difficile
Dhungel, B. A., & Govind, R. (2021) · Molecular Microbiology · doi:10.1111/mmi.14828 · Cited by 30
Evidence Map and Systematic Review of Disinfection Efficacy on Environmental Surfaces in Healthcare Facilities
Christenson, E., Cronk, R., Atkinson, H., Bhatt, A., Berdiel, E., Cawley, M. A., Cho, G., Coleman, C. K., Harrington, C., Heilferty, K., et al. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182111100 · Cited by 35

Authors: Lessa, F. C., Mu, Y., Bamberg, W. M., Beldavs, Z. G., Dumyati, G. K., Dunn, J. R., Farley, M. M., Holzbauer, S. M., Meek, J. I., Phipps, E. C., Wilson, L. E., Winston, L. G., Cohen, J. A., Limbago, B. M., Fridkin, S. K., Gerding, D. N., & McDonald, L. C.
Affiliations: National Center for Emerging and Zoonotic Infectious Diseases (US)
Colorado Department of Public Health and Environment (US)
Oregon Health Authority (US)
University of Rochester Medicine (US)
Tennessee Department of Health (US)
Emory University (US)
Office of Readiness and Response (US)
Yale University (US)
University of New Mexico (US)
Maryland Department of Health (US)
University of California, San Francisco (US)
Loyola University Chicago (US)
ORCID: Lessa, Fernanda C.
Mu, Yi
Bamberg, Wendy M.
Dumyati, Ghinwa K.
Dunn, John R.
Farley, Monica M.
Holzbauer, Stacy M.
Meek, James I.
Phipps, Erin C.
Wilson, Lucy E.
Fridkin, Scott K.
Gerding, Dale N.
McDonald, L. Clifford
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2015-02-26
Volume: 372
Issue: 9
Pages: 825-834
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmoa1408913
PMC: PMC10966662
OpenAlex: W2071054182
Cited by: 2,641
References: 44
Citations by year: 2026: 94 · 2025: 111 · 2024: 120 · 2023: 150 · 2022: 176 · 2021: 225 · 2020: 328 · 2019: 382 · 2018: 356 · 2017: 323 · 2016: 262 · 2015: 108
FWCI: 270.42
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: other-oa
Locations: New England Journal of Medicine (publishedVersion, other-oa)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Maryland Shared Open Access Repository (USMAI Consortium) (submittedVersion, public-domain)
eScholarship (California Digital Library) (submittedVersion)
Digital Repository at the University of Maryland (University of Maryland College Park) (public-domain)
Funders: National Institutes of Health (CC999999)
Centers for Disease Control and Prevention
Topics: Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
Keywords: Clostridium difficile infection, incidence, nosocomial infections, community-associated infections, recurrence, mortality, NAP1 strain, molecular typing, pulsed-field gel electrophoresis
MeSH terms: Adolescent, Adult, Aged, Child, Child, Preschool, Clostridium Infections, Cross Infection, Female, Humans, Infant, Male, Middle Aged, Population Surveillance, Recurrence, United States, Bacterial Typing Techniques, Incidence, Clostridioides difficile, Electrophoresis, Gel, Pulsed-Field, Age Distribution, Sex Distribution

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Burden of Clostridium difficile Infection in the United States

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks